Y136F CD4 T cells with the ability to trigger the production of Abs and of autoantibodies in a TCR-independent, quasi-mitogenic fashion. Therefore, despite the presence of autoantibodies causative of severe systemic disease, the pathological conditions observed in Lat Y136F mice unfold in an Ag-independent manner and thus do not qualify as a genuine autoimmune disorder.
L inker for activation of T cells (LAT)
4 is a transmembrane adaptor protein that assembles a multiprotein signaling complex through tyrosine-based motifs and links the TCR to intracellular pathways that regulate T cell development and function (for review, see Ref. 1). Analysis of T cells deprived of LAT suggested that it acts primarily as a positive regulator of TCR signaling. Mutant mice where tyrosine 136 of LAT was replaced with a phenylalanine (Lat Y136F mice) exhibit a partial developmental block at the two checkpoints that punctuate intrathymic ␣␤ T cell development (1, 2) . As a consequence, in 2-wk-old Lat Y136F mice, there were eight times fewer CD4 T cells in lymph nodes than in the wild-type (WT) control (3) . These ␣␤ ϩ CD4 T cells had already acquired an effector Th2 phenotype and embark in an uncontrolled polyclonal proliferation, leading to a 5-fold increase of CD4 T cells in secondary lymphoid organs of 6-week-old Lat Y136F mice as compared with the WT control. Owing to the stable Th2 effector phenotype of the expanding CD4 T cells, a massive polyclonal B cell activation ensued, resulting in hypergammaglobulinemia G1 (100-fold) and E (225,000-fold), as well as the production of autoantibodies (2, 3) . Two-to 3-mo-old Lat Y136F mice showed dense bronchovascular infiltrates and autoantibody deposits in the glomeruli of kidney that are associated with nephritis and proteinuria (3) . Therefore, LAT has dual functions in that it acts as a positive regulator of T cell development and also exerts a negative control on the homeostasis of peripheral T cells and on their differentiation into effector cells.
The polyclonal CD4 T cells that successfully mature in Lat Y136F mice are selected on and restricted by MHCII molecules (1) . It has been hypothesized that the Lat Y136F mutation results in a failure to eliminate self-reactive T cells during intrathymic negative selection (4) . According to that view, peripheral Lat Y136F CD4 T cells are thought to express autoreactive TCRs that react with self-peptides bound to MHCII molecules. Following engagement of these putative autoreactive TCRs, the lack of tyrosine 136 of LAT might create an imbalance among activating and inhibitory signaling pathways within individual CD4 T cells and trigger a feed-forward activation process resulting in the uncontrolled CD4 T cell differentiation and proliferation that characterize these mice. It has also been suggested that the presence of abnormal CD4
ϩ CD25 ϩ regulatory T cells in Lat Y136F mice contributes to the development of the lymphoproliferative disorder (5) . Based on the analysis of Lat Y136F mice expressing an MHCII-restricted TCR originally calibrated in a LAT-sufficient context, we have suggested that the decreased signals expected to emanate from the TCR-LATY136F signaling axis likely support the selection of only those CD4 ϩ CD8 ϩ thymocytes expressing TCR whose affinity for self is shifted toward higher values than in normal LAT-proficient background (6) . However, due to the presence of crippled LATY136F molecules, this increase in TCR affinity is likely cancelled out by a commensurate decrease in TCR output, and the TCR expressed by the CD4 T cells emerging in the Lat Y136F periphery should not display a strong autoreactivity.
Therefore, the available data leave open the issue of whether the Lat Y136F disorder constitutes a bona fide autoimmune pathology resulting from a defect in central tolerance and/or from the lack of regulatory T cells. The present study aims at elucidating this issue by identifying the triggers required for the unfolding of the lymphoproliferative disorder in the periphery of Lat Y136F mice. Using adoptive transfer experiments, we showed that the Lat Y136F disorder develops in the host periphery in the absence of TCR-MHCII interactions and depends on the presence of IL-7. Therefore, both the expansion and Th2-effector function of Lat Y136F CD4 cells do not result from an MHCII-driven, autoreactive process, a finding consistent with the fact that Lat Y136F CD4 T cells are largely refractory to TCR engagement (2, 7). Moreover, using Foxp3EGFP reporter mice, we revisited the involvement of regulatory T cells in the Lat Y136F disorder. We showed that CD25 Ϫ Foxp3 ϩ regulatory T cells exist in the periphery of Lat Y136F mice and are not functional. The TCR-independent proliferation manifested by Lat Y136F CD4 T cells can, however, escape the control of infused WT Foxp3 ϩ regulatory T cells. These results argue against a scenario where the Lat Y136F pathology is primarily due to a lack of functional Foxp3 ϩ regulatory T cells and suggest that a defect intrinsic to Lat Y136F CD4 T cells accounts for the unfolding of the lymphoproliferative disorder.
Materials and Methods

Mice
Mice were housed under specific pathogen-free conditions and handled in accordance with French and European directives. Unless specified otherwise, analyses were performed on 5-to 6-wk-old mice. Rag-2
⌬5/⌬5 (9), and Lat Y136F (1) mice have been described. Rag-2 Ϫ/Ϫ mice deficient in IL-7 have been described (10) . Cd3e ⌬5/⌬5 mice deficient in MHC class II molecules (Cd3e ⌬5/⌬ MHCII ⌬/⌬ mice) have been described (11) . All mice were on a C57BL/6 background.
Generation of Foxp3EGFP mice
A C57BL/6J BAC clone denoted RP23-54C14, and containing the mouse Foxp3 gene, was obtained from the Deutsches Ressourcenzentrum für Genomforschung (www.rzpd.de). A 7.7-kb targeting vector backbone encompassing exons 8 -11 and the 3Ј untranslated region of the Foxp3 gene was first subcloned using ET recombination (12) . The targeting vector backbone was next abutted with an HSV-thymidine kinase cassette. An IRES-EGFP-Cre-neo r cassette (13) was subsequently inserted through ET recombination into the 3Ј untranslated region of the Foxp3 gene, 361 bp downstream of the stop codon. Finally, the targeting vector was linearized by NotI before embryonic stem (ES) cell electroporation. After electroporation of Bruce4 C57BL/6J ES cells (14) and selection in G418 and gancyclovir, colonies were screened for homologous recombination by PCR and by Southern blot analysis with 5Ј and 3Ј single-copy probes, and with a neomycin probe. The 5Ј single-copy probe corresponded to a 493-bp XbaI-PstI fragment isolated from a Foxp3 genomic subclone. When tested on XbaI-digested DNA, it hybridized either to a 7.95-kb WT fragment or to a 6.4-kb recombinant fragment characteristic of the targeted FoxP3EGFP allele. The 3Ј single-copy probe corresponded to a 1.18-kb PstI-EcoRI fragment isolated from a Foxp3 genomic subclone. When tested on HindIII-digested DNA, it hybridized either to a 12.5-kb WT fragment or to a 10.5-kb recombinant fragment proper to the targeted Foxp3EGFP allele. Finally, a neo probe was used to ensure that adventitious nonhomologous recombination events had not occurred in the selected clones. Because the Bruce4 ES cells are of male origin, correctly targeted clones were hemizygotic for the FoxP3EGFP allele. Mutant ES cells were injected into FVB blastocysts. Screening of mice for the presence of the IRESEGFP insertion was performed by PCR using the following oligonucleotides: FoxP3-001 5Ј-GCC AAT CCC AGC CTA GCC CCT AGT-3Ј, FoxP3-002 5Ј-CAG CTG ACC ACA GTT TAT TGG ATG-3Ј, EGFP 5Ј-CAA GTC CGC CAT GCC CGA AGG CTA CG-3Ј. The primer pair specific for the Foxp3 gene (FoxP3-001 and FoxP3-002) amplifies a 650-bp fragment, and the primer pair specific for the Foxp3EGFP allele (FoxP3-002 and EGFP) amplifies a 1-kb fragment.
Cell isolation
CD4 T cells were purified from lymph nodes and spleens from WT and Lat Y136F mice using a CD4 magnetic microbeads labeling kit and an autoMACS magnetic cell sorter (Miltenyi Biotech 
CD25
Ϫ fractions using a FACSVantage cell sorter (BD Biosciences), CD4 T cells were first enriched using a kit permitting to eliminate CD4
Ϫ cells (Dynal Biotech). 
Adoptive transfer of CD4 T cells
CD4 T cells (3 ϫ 10 6 in 150 l) were injected i.v. into recipient mice. Spleen and lymph nodes were recovered at various times after transfer. When indicated, purified CD4 T cells were labeled with CFSE (Molecular Probes, Invitrogen) before injection. Spleen and lymph nodes were recovered and CFSE content was analyzed after gating on CD4 ϩ CD5 ϩ T cells.
Neonatal transfer of T cells
Foxp3EGFP mice were injected i.p. into 2-to 4-day-old Lat Y136F neonates (3 ϫ 10 5 cells in a final volume of 20 l). Mice were bled 4 wk after injection to monitor the extent of transfer, and they were then analyzed at 8 wk of age. 
Mixed bone marrow chimeras
Abs and flow cytometry
Before staining, cell suspensions were preincubated at 4°C for at least 10 min with the Ab 2.4G2 to block Fc receptors. Single-cell suspensions were stained for 30 min with combinations of FITC-, PE-, Percp-Cy5-5, and APC-, PE-Cy7-, or APC-cy7-conjugated Abs (BD Pharmingen and eBioscience). For Foxp3 intracellular staining, cells were first labeled with Abs directed against surface markers, fixed, and permeabilized with Cytofix/ Cytoperm buffer (BD Pharmingen) for 20 min at 10°C. Cells were washed twice with Perm/Wash buffer (BD Pharmingen) and stained with antiFoxp3-PE Ab (eBioscience) for 30 min. Flow cytometric analysis was performed on an LSRI system or a BD FACSCanto II flow cytometry (BD Biosciences). Acquisition was performed with BD FACSDiva software (BD Biosciences) and analysis with a FlowJo (Tree Star) software.
Determination of serum IgG1 and IgE concentration
The concentration of IgG1 and IgE were determined as described (15) .
Results
The Lat
Y136F disorder is T cell autonomous A total of 3 ϫ 10 6 CD4 T cells purified from WT mice were labeled with CFSE (an intracytoplasmic dye whose intracellular amount is halved at each cell division) and transferred i.v. into histocompatible, CD3e-deficient (Cd3e ⌬5/⌬5 ) mice. Cd3e
⌬5/⌬5
hosts are deprived of T cells but harbor B cells (9) and can therefore aid in assessing the impact the transferred T cells have on B cells. As previously described, two coincident and independent phenomena occurred following transfer of WT CD4 T cells into constitutively immunodeficient mice, including Cd3e ⌬5/⌬5 mice (11, 16, 17) . The vast majority of transferred CD4 T cells proliferated very slowly and retained a naive phenotype, which accounts for the CFSE ϩ peaks observed 6 days after transfer (Fig. 1A and data not shown). In contrast, a small proportion of injected WT CD4 T cells proliferated in an explosive manner, yielding the prominent peak of CFSE Ϫ cells observed 6 days after transfer (Fig.  1A) . These CFSE Ϫ CD4 ϩ cells displayed a memory-effector phenotype (Fig. 2 , B and C), and their generation has been shown to be independent of IL-7 but strictly dependent on interactions with MHCII molecules (11, 16, 17) . It has been further suggested that antigenic peptides derived from enteric bacteria present in constitutively immunodeficient hosts trigger this fast proliferation (17) . The fast and slow proliferation displayed by WT CD4 cells does not fully restore the peripheral T cell compartment of Cd3e
hosts (18) . For instance, 8 wk after transfer, 6.4 ϫ 10 6 CD4 T cells were recovered on average per spleen, and their impact on endogenous B cells was limited to the normalization of the levels of serum Ig to values close to those found in Cd3e-sufficient mice ( Fig. 2A and cells only proliferated slowly (Fig. 1A) . However, in contrast to transferred WT CD4 T cells, this slow proliferation continued unabated, and the CFSE ϩ peaks observed at day 6 after transfer progressively converted over the following weeks into a single CFSE Ϫ peak (Fig. 3A) . Splenomegaly and lymphadenopathy ensued, and 8 wk after transfer the number of Lat Y136F CD4 T cells reached ϳ83.8 ϫ 10 6 per spleen (Fig. 2) . Therefore, the magnitude of the proliferation observed upon adoptive transfer of Lat Y136F CD4 T cells was 13-fold higher compared with the proliferation observed when WT CD4 T cells were transferred into Cd3e
hosts. The phenotype of Lat Y136F CD4 cells did not change following their expansion into Cd3e ⌬5/⌬5 hosts. They conserved an effector phenotype and continued to express low levels of TCR at their surface (Fig. 2, B and C) . Moreover, the expanding Lat Y136F CD4 T cells had a dramatic effect on the resident B cells, massively inducing their proliferation and triggering IgG1 and IgE hypergammaglobulinemia (Figs. 2A and 3B). Before adoptive transfer, IgE and IgG1 were present at very low concentrations in the serum of Cd3e ⌬5/⌬5 mice. Eight weeks after transfer of Lat Y136F CD4 T cells, serum levels of IgG1 and IgE reached concentrations of 35.4 mg/ml and 846.1 g/ml, respectively (Fig. 2) . This corresponds to an 84-fold and an 8460-fold elevation of IgG1 and IgE concentrations, respectively, compared with the levels observed in Cd3e ⌬5/⌬5 hosts infused with WT CD4 T cells ( Fig. 2A ). Lat Y136F CD4 T cells have an effector phenotype and thus differ from the CD4 T cells purified from WT mice. To exclude that the different behavior of the adoptively transferred WT and Lat
Y136F
CD4 T cells was due to their distinct activation status, WT CD4 T cells were activated and expanded in vitro using anti-CD3 and anti-CD28 Abs before their transfer. Eight weeks after transfer into Cd3e ⌬5/⌬5 hosts, 18.7 ϫ 10 6 CD4 T cells were recovered on average per spleen and no hypergammaglobulinemia ensued (data not shown). Such behavior resembles that of memory CD44 high CD4 T cells prepared from 6-to 12-mo-old WT mice and transferred into hosts deprived of T cells (19) 
MHCII
⌬/⌬ hosts that expressed neither conventional nor mixed isotype (A ␣ E ␤ ) MHCII molecules (11, 20) . After transfer into Cd3e ⌬5/⌬5 MHCII ⌬/⌬ hosts, the CFSE profiles of WT CD4 T cells differed from those observed in MHCII-sufficient hosts in that they lacked the peak corresponding to the fast proliferating cells (Fig.  3A, left panels) . In contrast, comparable CFSE profiles were observed upon transfer of Lat Y136F CD4 T cells into Cd3e ⌬5/⌬5 hosts that were MHCII-sufficient or -deficient. In both instances, the CFSE ϩ peaks observed 6 days after transfer progressively converted into a CFSE Ϫ peak over the following days (Fig. 3, right  panels) . Therefore, the absence of MHCII molecules does not affect the characteristic slow but continuous proliferation of transferred Lat Y136F CD4 T cells. Absolute numbers of CD4 T cells were also assessed at later time points after transfer to take into account both cell proliferation and cell survival. Eight weeks following transfer, 147.5 Ϯ 34.3 ϫ 10 6 (n ϭ 10) and 60. (Fig. 3B and data not  shown) . The extent of hypergammaglobulinemia G1 and E was only slightly affected by the lack of MHCII molecules (Fig. 3B) (Fig. 3B) . This may indirectly result from the two-fold reduction in the magnitude of the Lat Y136F CD4 T cell proliferation observed in Cd3e ⌬5/⌬5 MHCII ⌬/⌬ mice (Fig. 3) . Importantly, activated B cells were all MHCII Ϫ and therefore do not originate from the expansion of a few MHCII ϩ , donor-derived B cells that might have adventitiously contaminated the adoptively transferred Lat Y136F CD4 T cells (data not shown). Therefore, based on the use of hosts fully deprived of MHCII molecules, our results confirm that the constitutive T-B cooperation at play in Lat Y136F mice, responsible for hypergammaglobulinemia E and G1, occurs irrespective of the presence of MHCII ligands on B cells.
Proliferation of transferred Lat
Y136F CD4 T cells requires IL-7
Several studies have highlighted the role played by IL-7 in the homeostasy of naive and memory CD4 T cells (23) (24) (25) . Therefore, we asked whether IL-7 is required for the Lat Y136F lymphoproliferative disorder using RAG-2-deficient hosts that have an additional deficiency in the gene coding for IL-7 (Rag-2 Ϫ/Ϫ Il-7
mice (10)). Nine days after transfer into IL-7-sufficient Rag-2
hosts, Lat Y136F CD4 T cells showed a CFSE profile identical with (Fig. 1B) . Therefore, similar to slowly proliferating, WT CD4 T cells (Fig. 1B, left panels) , Lat Y136F CD4 T cells expand in an IL-7-dependent manner. Interestingly, the absence of IL-7 had a minimal impact on the survival of Lat Y136F CD4 T cells because 9 days after transfer, the numbers of Lat Y136F CD4 T cells recovered from Rag-2 Ϫ/Ϫ Il-7 Ϫ/Ϫ hosts was only 2.5-fold lower than those recovered from Rag-2 Ϫ/Ϫ hosts (data not shown). Therefore, the availability of IL-7 dramatically influenced the ability of Lat Y136F CD4 cells to expand following adoptive transfer into lymphopenic hosts, with IL-7 absence having far more negative consequences than the removal of MHCII molecules.
Cotransfer of WT CD4 T cells or of Foxp3 ϩ regulatory T cells prevents expansion of Lat Y136F CD4 T cells
Bone marrow cells from WT (CD45.1 ϩ ) and Lat Y136F (CD45.2 ϩ ) mice were injected into sublethally irradiated Rag-2 Ϫ/Ϫ mice, and chimeras were analyzed 10 wk later. The thymus and spleen of Rag-2 Ϫ/Ϫ mice that only received WT bone marrow cells showed a normal complement of T cells (Fig. 4 and data not shown) . As expected, thymi of Rag-2 Ϫ/Ϫ mice injected with Lat Y136F bone marrow cells were hypocellular, and the numbers of T cells found in the spleen were 11.8-fold higher than those found in Rag-2 Ϫ/Ϫ mice reconstituted with WT bone marrow cells (Fig. 4) . Splenomegaly resulted from expansion of CD4 Th2 effector cells and of activated B cells (data not shown). Analysis of thymi from Rag-2 Ϫ/Ϫ mice reconstituted with a 1:1 mixture of WT and Lat
Y136F
bone marrow cells showed that up to TCR␤-selection, WT and Lat Y136F -derived double-negative cells were evenly represented (data not shown). By competing with WT thymocytes for stromal niches (26) , and generating fewer double-positive thymocytes (1), Lat Y136F -derived, double-negative cells likely account for the approximately three-fold reduced numbers of thymic cells observed in the mixed bone marrow chimeras (Fig. 4) . Interestingly, the presence of peripheral, WT CD4 T cells in the mixed bone marrow chimeras prevented the few Lat Y136F CD4 T cells that managed to reach the periphery to embark into a proliferative disorder (Fig. 4) .
This last observation prompted us to test whether cotransfer of Lat Y136F CD4 T cells and of WT CD25 Ϫ CD4 T cells into Cd3e ⌬5/⌬5 hosts would similarly prevent the proliferation of Lat Y136F CD4 T cells. Even when mixed at a 1:10 ratio, WT CD25 Ϫ CD4 T cells readily suppressed the proliferation of the Lat Y136F CD4 T cells (Fig. 5, left panels) and their ability to activate endogenous B cells (data not shown). In contrast, when injected at a 1:10 ratio into Cd3e ⌬5/⌬5 MHCII ⌬/⌬ mice, WT CD25 Ϫ CD4 T cells were unable to prevent the MHCII-independent, Lat Y136F CD4 T cell proliferation (Fig. 6, right panels) . Therefore, the WT CD4 T cells that transiently expand in an explosive and MHCII-dependent manner upon transfer into MHCIIsufficient Cd3e ⌬5/⌬5 hosts (Fig. 3) in the periphery of the mixed bone marrow chimeras (Fig. 4) . Therefore, in contrast to the "neutral" behavior of endogenous B cells present in Cd3e ⌬5/⌬5 host, the presence of WT CD4 T cells was capable of controlling the capacity of the pathogenic Lat Y136F CD4 T cells to expand and activate B cells.
We tested next whether regulatory T cells that express the Foxp3 transcription factor could also control the proliferation of Lat Y136F CD4 T cells upon cotransfer into Cd3e ⌬5/⌬5 hosts. Foxp3 ϩ regulatory T cells were purified from WT mice expressing a Foxp3-driven EGFP reporter (see below) and were mixed at a 1:10 ratio with Lat Y136F CD4 T cells. Following cotransfer into Cd3e ⌬5/⌬5 hosts, WT Foxp3 ϩ CD4 ϩ regulatory T cells behaved as WT CD4 ϩ CD25 Ϫ T cells in that they prevented the proliferation of Lat Y136F CD4 T cells (Fig. 5, left  panels) . Consistent with the view that regulatory T cells require TCR engagement to exert suppression (27) 
Foxp3EGFP thymi were CD25 Ϫ to CD25 low (Fig. 7A ). EGFP ϩ CD4 ϩ cells were also present in the secondary lymphoid organs of Lat Y136F Foxp3EGFP mice, and they expressed levels of Foxp3 transcription factor similar to the EGFP ϩ CD4 ϩ cells found in Foxp3EGFP mice (Fig. 7B) . In contrast, the pathogenic CD4 ϩ Th2 effectors that expand in Lat Y136F mice were EGFP Ϫ (Fig. 7B ). Considering the cellularity of WT Foxp3EGFP (mean of 87 ϫ 10 6 cells) and Lat Y136F Foxp3EGFP (mean of 596 ϫ 10 6 cells) spleens, it can be calculated that the absolute numbers of EGFP ϩ regulatory T cells is only 1.5-fold reduced in the spleen of Lat Y136F Foxp3EGFP mice. The EGFP ϩ cells found in Lat Y136F Foxp3EGFP spleen were CD25 Ϫ and expressed levels of CD3, CD44, CD62L, and CD69 that resemble those found on the CD4 ϩ CD25 Ϫ cells that expand in Lat Y136F mice (Fig. 7C) . When tested in vitro for their functional ability, EGFP ϩ CD4 ϩ regulatory T cells purified from Lat Y136F Foxp3EGFP mice differed from the EGFP ϩ CD4 ϩ regulatory T cells isolated from WT Foxp3EGFP mice in that they were unable to suppress TCR-induced proliferative responses of WT CD4 T cells (data not shown). Therefore, although a slightly reduced number of Foxp3 ϩ CD4 ϩ regulatory T cells can be found in the periphery of Lat Y136F mice, they are CD25 Ϫ and not functional.
Lat
Y136F CD4 cells escape the control of Foxp3 ϩ regulatory T cells
To assess whether WT regulatory T cells can control pathogenic Lat Y136F CD4 T cells in a more physiological set-up than that offered by adoptive transfer into Cd3e ⌬5/⌬5 hosts, EGFP ϩ CD4 ϩ regulatory T cells were sorted with FACS from WT Foxp3EGFP mice and injected into 2-to 4-day-old Lat Y136F neonates. Because almost no endogenous CD4 T cells are present in the periphery of Lat Y136F neonates (3), this protocol should provide enough time for proliferation and activation of the transferred WT regulatory T cells and allow them to outnumber the first cohort of CD4 T cells that emerges from the thymus. EGFP expression allowed us to monitor the level of regulatory T cell engraftment and showed that 7 wk after neonatal transfer of 3 ϫ 10 5 EGFP ϩ CD4 ϩ regulatory T cells, the spleen of Lat Y136F mice contained from 1 to 5 ϫ 10 6 EGFP ϩ CD4 ϩ regulatory T cells (Fig. 8A) . However, 7 wk after transfer of EGFP ϩ CD4 ϩ regulatory T cells, the spleens of Lat Y136F mice also contained an average of 142 ϫ 10 6 Lat Y136F -derived CD4 T cells that triggered coincident B cell activation, splenomegaly, and hypergammaglobulinamia E and G1 (Fig. 8, A  and C 
Discussion
We showed that adoptive transfer of Lat Y136F CD4 T cells into Cd3e ⌬5/⌬5 hosts suffices to recapitulate the rapid-onset, Th2 lymphoproliferative disorder that characterizes Lat Y136F mutant mice. Upon transfer, Lat Y136F CD4 T cells have thus kept their Th2 effector property and proliferative potential. Unexpectedly, their expansion and effector functions were found independent of the presence of MHCII molecules, suggesting that, after successfully developing on the basis of TCR-MHCII interactions, the Lat Y136F CD4 T cells that reach the periphery convert into a state where they are largely "autistic" to TCR-derived inputs. Moreover, the presence of elevated numbers of activated B cells and of hypergammaglobulinemia E and G1 in hosts lacking all MHCII molecules shows that TCR-MHCII interactions are even not required for induction of class-switch recombination and hypergammaglobulinemia E and G1 by Lat Y136F CD4 T cells. Therefore, Lat Y136F CD4 T cells help B cells in an MHCII-independent, "quasi-mitogenic" mode that results in the production of autoantibodies among other Abs (3). In contrast, Ab responses are profoundly blunted in MHCII-deficient mice expressing WT CD4 T cells (30) . The spectrum of TCR V␤ usage among CD4 T cells expanding in the absence of MHCII molecules was similar to that found in CD4 T cells expanding in MHCII-sufficient hosts (data not shown). This suggests that in the absence of MHCII molecules there is no contraction of the TCR repertoire indicative of the selection of unique TCR specificities, and it further supports the view that TCR engagement is not required for the Lat Y136F lymphoproliferative disorder.
Lat Y136F CD4 T cells can, however, still respond to environmental cues since their expansion is totally dependent on the presence of IL-7. Interestingly, 6 wk after transfer into Cd3e
⌬5/⌬5
hosts, Lat Y136F CD4 T cell expansion reached a plateau corresponding to ϳ80 ϫ 10 6 cells per spleen (Fig. 2 ). This suggests that at early time points enough IL-7 is available in Cd3e
hosts to promote both the survival and proliferation of the Lat Y136F CD4 T cells, whereas at later time points, as their numbers increased, IL-7 can become limiting, promoting their survival without further proliferation. However, it remains to be determined whether IL-7 is sufficient to drive the expansion of the Lat Y136F CD4 T cells, or whether it plays a permissive role by maintaining a favorable metabolic state averting cell death and allowing other receptors to mediate G1 progression and cell proliferation (31) . Importantly, Lat Y136F CD4 T cells showed a rather unique proliferative behavior in that they do not manifest the explosive and transient kinetics of proliferation that characterize CD4 T cells embarking in Ag-driven responses. As soon as they emerge from the thymus or are adoptively transferred into hosts deprived of T cells, Lat Y136F CD4 T cells receive stimuli that result in a slow but sustained expansion and manifest full-fledged Th2 effector functions. This behavior also differs from WT CD4 T cells undergoing slow homeostaticinduced proliferation (11, 16, 17 hosts, Lat Y136F CD4 T cell effectors showed a gradual diminution of their replicative capacity. A similar replicative exhaustion has been observed for effector T cells during persistent Ag stimulation (32, 33) . This may explain that Foxp3 ϩ regulatory T cells can control the limited proliferative potential of adoptively transferred Lat Y136F CD4 T cells purified from 4-to 6-wk-old mice but are overwhelmed by the one manifested by Lat Y136F CD4 T cells emerging from neonatal thymi. Lat Y136F mice cannot be cured by neonatal adoptive transfer of Foxp3 ϩ regulatory T cells, and thus they differ from Foxp3-deficient mice and from lymphopenic mice reconstituted with a limited repertoire of CD4 T cells (34, 35) . Moreover, the survival kinetics and abnormalities that characterize Foxp3-deficient and Lat Y136F mice are markedly distinct (36, 37) . This suggests that features intrinsic to the Lat Y136F CD4 T cells, as well as features yet to be discovered, contribute to the Th2 lymphoproliferative disorder. Accordingly, the trigger of the Lat Y136F pathology is likely due to a defect in a cell-intrinsic mechanism that keeps CD4 T cells in check, and the consequences of this defect are further exacerbated by the lack of cell-extrinsic suppressive mechanisms mediated by Foxp3 ϩ regulatory T cells. Peripheral CD4 and CD8 T cells with TGF-␤-receptor II deficiency trigger a TCR-specific-dependent, autoimmune pathology and manifest a high pathogenic potential even in the presence of WT regulatory T cells (38) . Effector T cells from mice deficient in Cbl-b or TRAF6 were also capable of escaping from suppression by Foxp3 ϩ regulatory T cells (39) . Therefore, the Lat Y136F CD4 T cells constitute another example of immune effectors that due to an intrinsic signaling abnormality became resistant to the suppressive action of WT Foxp3 ϩ regulatory T cells (39) . In WT mice, Foxp3 ϩ regulatory T cells keep in check T cells that are reactive to self-and environmental Ags and limit the magnitude of immune responses in vivo through poorly defined mechanisms (40) . The mechanisms underlying the resistance of effector T cells expressing Lat Y136F molecules or deprived of Cbl-b, TRAF6, or TGF-␤-receptor II are as yet unclear.
The slow but continuous proliferation manifested by Lat Y136F CD4 T cells contrasts with the explosive proliferation manifested by the CD4 T cells that emerge in the periphery of Ctla-4 and Foxp3-deficient mice and that are hyper-responsive to TCR signals (41) (42) (43) (44) . The autoimmune process and inflammatory pathology that characterize Ctla-4 and Foxp3-deficient mice are thought to occur through TCR-mediated recognition of environmental and/or self-Ags. Consistent with that view, withdrawing or narrowing the source of Ags does prevent the Ctla-4 and Foxp3 lymphoproliferative disorders (45, 46) . In contrast, the Lat Y136F lymphoproliferative disorder, including the production of autoantibodies, does not involve TCR-MHCII interactions and therefore does not qualify as a TCR-specifity-dependent autoimmune disease. Therefore, it is possible that some pathological conditions coined as "autoimmune" due to the presence of autoantibodies do not result from a failure of central or peripheral T cell tolerance but instead result from a defect in TCR-operated, negative feedback loops that control T cell hyper-reactivity. Therefore, attempting to identify the autoantigens that trigger such types of disorders constitutes a vain task. Along that line, note that Ag-independent mechanisms have been also recently suggested to account for the B cell hyperreactivity noted in MRL mice (47) . In conclusion, the Lat Y136F mutation might thus constitute a first example of a mutation that by disturbing the complex signaling hierarchy that is intrinsic to T cell activation renders both the proliferation and function of CD4 Th2 cells independent of the control of the TCR.
